Piramal Pharma is investing USD 85 million this fiscal for initiatives like capacity expansion and maintenance. They have already used USD 30 million in the first half. Part of the funds will be for domestic use and some for the US. The company aims to reach USD 2 billion in revenue by FY30. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
